Abstract
An outline is provided of the development of methodological strategies to address the question of focal cerebral activation during hallucinations in schizophrenic patients. In so doing, the innovation and diligence required to tailor in vivo tracer procedures to specific clinical research issues are highlighted. Attention is drawn to the complexity of methodological advances and the way in which they are based upon close scientific and technical collaboration between clinical scientists, and non-clinical scientists and research support staff.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Merton RK. Social theory and social structure, enlarged edition. New York: Free Press, 1968, p. 4.
Silbersweig DA, Stern E, Frith C, Cahill C, Holmes A, Grootoonk S, Seaward J, McKenna P, Chua SE, Schnorr L, Jones T, Frackowiak RSJ. A functional neuroanatomy of hallucinations in schizophrenia.Nature 1995, 378: 176–179.
Bailey DL, Jones T, Spinks TJ, Gilardi M-C, Townsend DW. Noise equivalent count measurements in a neuro-PET scanner with retractable septa.Med Imag 1991; 10: 256–260.
Spinks TJ, Jones T, Bailey DL, Townsend DW, Grootoonk S, Bloomfield PM, Gilardi M-C, Casey ME, Sipe B, Reed J. Physical performance of a positron tomograph for brain imaging with retractable septa.Phys Med Biol 1992; 37: 1637–1655.
Bailey DL, Jones T, Watson JDG, Schnorr L, Frackowiak RSJ. Activation studies in 3D PET: evaluation of true signal gain. In: Uemura K, Lassen NA, Jones T, Kanno I eds. Quantification of brain function. Tracer kinetics and image analysis in brain PET. Amsterdam New York: Elsevier Science; 1993: 341–349.
Silbersweig DA, Stern E, Frith CD, Cahill C, Schnorr L, Grootoonk S, Spinks T, Clark J, Frackowiak R, Jones T. Detection of thirty-second cognitive activations in single subjects with positron emission tomography: a new low-dose H2 15O regional cerebral blood flow three-dimensional imaging technique.J Cereb Blood Flow Metab 1993; 13: 617–629.
Clark J, Dowsett K, Steel CJ, Turton D. The Hammersmith philosophy for PET chemistry automation. In: Emran AM, ed. Chemists' views of imaging centers 1995. New York: Plenum; 1995: 431–443.
Smith T, Tong C, Lammertsma AA, Butler K, Schnorr L, Watson DG, Ramsay S, Clark JC, Jones T. Dosimetry of intravenously administered oxygen-15 labelled water in man: a model based on experimental human data from 21 subjects.Eur J Nucl Med 1994; 21: 1126–1134.
Silbersweig DA, Stern E, Schnorr L, Frith CD, Ashburner J, Cahill C, Frackowiak RST, Jones T. Imaging transient, randomly occurring neuropsychological events in single subjects with positron emission tomography: an event-related count rate correlation analysis.J Cereb Blood Flow Metab 1994; 14: 771–782.
Friston KJ, Holmes AP, Worsley KJ, Poline JP, Frith CD, Frackowiak RSJ. Statistical parametric maps in functional imaging: a general linear approach.Human Brain Mapping 1995; 2: 617–629.
Stern E, Silbersweig DA, Grootoonk S, Schnorr L, Seaward J, Frith CD, Frackowiak RSJ. A comparison of measured, calculated and no attenuation correction for PET activation studies.J Nucl Med 1994; 35 (5 Suppl): 181.
Stern E, Silbersweig DA, Clifford K, Lewington G, Schnorr L, Jones T, Frackowiak RSJ. A new head-holder for positron emission tomography studies.J Nucl Med 1995; 35 (5 Suppl): 186.
Dolan RJ, Fletcher P, Frith CD, Friston KJ, Frackowiak RSJ, Grasby PM. Dopaminergic modulation of impaired cognitive activation in the anterior cingulate cortex in schizophrenia.Nature 1995; 378: 180–182.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Jones, T., Silbersweig, D.A., Stern, E. et al. The development of in vivo tracer methods to obtain new information about human disease: a study of the hallucinating brain. Eur J Nucl Med 23, 332–335 (1996). https://doi.org/10.1007/BF00837633
Issue Date:
DOI: https://doi.org/10.1007/BF00837633